Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 72819-152

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 72819-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Archis Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-5 mg (5mgcartonlabel)

Mitomycin for Injection, USP 5 mg/vial lyophilized powder for intravenous solution by Archis Pharma LLC. The carton panels display dosage strength, warnings about intravenous administration, handling instructions, storage conditions, and distributor information. The label highlights it as a single-dose vial, sterile, and RX only, with branding from Novaplus.*

FDA Label Image

Label-5 mg (5mglabel)

Label for Mitomycin for Injection, USP 5 mg/vial, lyophilized powder for intravenous injection by Archis Pharma LLC. Includes dosage warnings, storage instructions, and handling information. The label notes the product is a single dose vial, sterile, made in India, with references to dilution and cytotoxic handling procedures.*

FDA Label Image

Structural Formula (Structure)

Chemical structure of Mitomycin as shown in the image, depicting its molecular arrangement with labeled functional groups and atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.